Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02370511 · ClinicalTrials.gov registry record · NA
Mitral Implantation of TRAnscatheter vaLves
A NA study, sponsored by Mayra Guerrero.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT02370511 is a NA study that has completed, run by Mayra Guerrero. The registered enrollment target is 91 participants.
The verdict
NCT02370511, a NA study, has completed, sponsored by Mayra Guerrero.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
The purpose of this trial is to establish the safety and feasibility of the Edwards SAPIEN XT™and SAPIEN 3™ device and delivery systems in patients with severe symptomatic calcific mitral valve disease with severe mitral annular calcification who are not candidates for standard mitral valve surgery.
Interventions
- DEVICE Transcatheter Mitral Valve Replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2015-02-25 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02370511
The ClinicalTrials.gov registry entry for NCT02370511 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayra Guerrero, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcatheter Mitral Valve Replacement is the first listed.
NCT02370511 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02370511 about?
NCT02370511 is a clinical study titled "Mitral Implantation of TRAnscatheter vaLves". The purpose of this trial is to establish the safety and feasibility of the Edwards SAPIEN XT™and SAPIEN 3™ device and delivery systems in patients with severe symptomatic calcific mitral valve disease with severe mitral annular calcification who are not candidates for standard mitral valve surgery.
What is the current status of trial NCT02370511?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2015-02-25. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02370511?
The interventions under investigation include: Transcatheter Mitral Valve Replacement (DEVICE).
Who is sponsoring clinical trial NCT02370511?
This trial is sponsored by Mayra Guerrero, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.